PT1252155E - Solvato de etanol de (-)-cis-2-(2-clorofenil)-5,7-di-hidroxi-8-[4r-(3s-hidroxi-1-metil)piperidinil]-4h-1-bezopiran-4-ona - Google Patents

Solvato de etanol de (-)-cis-2-(2-clorofenil)-5,7-di-hidroxi-8-[4r-(3s-hidroxi-1-metil)piperidinil]-4h-1-bezopiran-4-ona

Info

Publication number
PT1252155E
PT1252155E PT01902993T PT01902993T PT1252155E PT 1252155 E PT1252155 E PT 1252155E PT 01902993 T PT01902993 T PT 01902993T PT 01902993 T PT01902993 T PT 01902993T PT 1252155 E PT1252155 E PT 1252155E
Authority
PT
Portugal
Prior art keywords
piperidinyl
chlorophenyl
dihydroxy
cis
hydroxy
Prior art date
Application number
PT01902993T
Other languages
English (en)
Inventor
Kurt M Kesseler
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of PT1252155E publication Critical patent/PT1252155E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PT01902993T 2000-01-18 2001-01-08 Solvato de etanol de (-)-cis-2-(2-clorofenil)-5,7-di-hidroxi-8-[4r-(3s-hidroxi-1-metil)piperidinil]-4h-1-bezopiran-4-ona PT1252155E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18

Publications (1)

Publication Number Publication Date
PT1252155E true PT1252155E (pt) 2005-04-29

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01902993T PT1252155E (pt) 2000-01-18 2001-01-08 Solvato de etanol de (-)-cis-2-(2-clorofenil)-5,7-di-hidroxi-8-[4r-(3s-hidroxi-1-metil)piperidinil]-4h-1-bezopiran-4-ona

Country Status (26)

Country Link
EP (1) EP1252155B1 (pt)
JP (1) JP2003520798A (pt)
KR (1) KR100825530B1 (pt)
CN (1) CN1395577A (pt)
AR (1) AR027226A1 (pt)
AT (1) ATE284400T1 (pt)
AU (1) AU2001230869A1 (pt)
BR (1) BR0107724A (pt)
CA (1) CA2397594C (pt)
CZ (1) CZ301235B6 (pt)
DE (1) DE60107652T2 (pt)
DK (1) DK1252155T3 (pt)
EA (1) EA005182B1 (pt)
ES (1) ES2228800T3 (pt)
HU (1) HU225155B1 (pt)
IL (2) IL150643A0 (pt)
MX (1) MXPA02006965A (pt)
NO (1) NO322626B1 (pt)
NZ (1) NZ520281A (pt)
PL (1) PL201690B1 (pt)
PT (1) PT1252155E (pt)
SI (1) SI1252155T1 (pt)
SK (1) SK287216B6 (pt)
TW (1) TWI293072B (pt)
WO (1) WO2001053294A1 (pt)
ZA (1) ZA200205640B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109803684B (zh) 2016-08-23 2022-08-23 卫材 R&D 管理有限公司 用于治疗肝细胞癌的组合疗法
EP4218820A3 (en) 2017-03-16 2023-09-20 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (pt) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
DE60107652T2 (de) 2005-12-22
ZA200205640B (en) 2003-11-26
SK287216B6 (sk) 2010-03-08
NO20023385D0 (no) 2002-07-12
HU225155B1 (en) 2006-07-28
DK1252155T3 (da) 2005-04-04
KR20020069514A (ko) 2002-09-04
JP2003520798A (ja) 2003-07-08
ES2228800T3 (es) 2005-04-16
MXPA02006965A (es) 2004-09-06
EP1252155A1 (en) 2002-10-30
IL150643A (en) 2009-08-03
WO2001053294A1 (en) 2001-07-26
NO322626B1 (no) 2006-11-06
CA2397594C (en) 2010-03-23
TWI293072B (en) 2008-02-01
SI1252155T1 (en) 2005-06-30
EA200200776A1 (ru) 2002-12-26
EA005182B1 (ru) 2004-12-30
IL150643A0 (en) 2003-02-12
NZ520281A (en) 2004-04-30
CA2397594A1 (en) 2001-07-26
CZ301235B6 (cs) 2009-12-16
AR027226A1 (es) 2003-03-19
EP1252155B1 (en) 2004-12-08
PL355992A1 (en) 2004-05-31
KR100825530B1 (ko) 2008-04-25
BR0107724A (pt) 2002-10-01
NO20023385L (no) 2002-08-27
SK10372002A3 (sk) 2002-12-03
CN1395577A (zh) 2003-02-05
HUP0204297A3 (en) 2005-04-28
PL201690B1 (pl) 2009-04-30
DE60107652D1 (de) 2005-01-13
AU2001230869A1 (en) 2001-07-31
HUP0204297A2 (hu) 2003-04-28
ATE284400T1 (de) 2004-12-15
CZ20022467A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
AU2001259961A1 (en) Method and technology for high-throughput lead profiling
AU2002211652A1 (en) Method of making an electrode
AU2002220113A1 (en) Large character set browser
PL345236A1 (en) Novel benzenesulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
AU2001261631A1 (en) Answering natural language queries
PT1252155E (pt) Solvato de etanol de (-)-cis-2-(2-clorofenil)-5,7-di-hidroxi-8-[4r-(3s-hidroxi-1-metil)piperidinil]-4h-1-bezopiran-4-ona
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
NO20023386D0 (no) Pseudopolymorf av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on
AU2001255821A1 (en) Enhanced production of secondary metabolites in the presence of organic additives
AUPQ621600A0 (en) Grand piano action
DE69813576D1 (de) Ethanolherstellung durch mutanthefe
AU2002343178A1 (en) Method to query an embebbed database
AU3423101A (en) Method for making information available by telephone
AU2001223955A1 (en) Method for searching internet domain names
ATE244214T1 (de) Phosphat-vermittelte cyclisierung
AU2001265700A1 (en) Method of sentence analysis
AR027225A1 (es) Pseudopolimorfo de (-)-cis-2-(2-clorofenil)-5,7-dihidroxi-8[4r(3s-hidroxi-1-metil)piperdinil]-4h-1-benzopiran-4-ona
AU2001284421A1 (en) Method of determining base sequence
AU2001280324A1 (en) Method for producing an injection laser